Diabetes drug may benefit Alzheimer's patients, study says

12/21/2012 | United Press International

An experimental drug called AC253, which was designed to treat diabetes, could block the effects of amyloid proteins that cause brain cells to die in patients with Alzheimer's disease, Canadian researchers say. The study, reported in The Journal of Neuroscience, showed that when the drug was injected into brain cells of an animal model with Alzheimer's disease, memory function was restored to near-normal levels.

View Full Article in:

United Press International

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ